AstraZeneca-Bristol Myers merger talks reported at nearly $400bn value
The Financial Times says AstraZeneca and Bristol Myers Squibb have discussed a tie-up, though neither company has confirmed a deal...
By Marcus V. Thorne 2 months agoSection
The Financial Times says AstraZeneca and Bristol Myers Squibb have discussed a tie-up, though neither company has confirmed a deal...
By Marcus V. Thorne 2 months agoGlitter Bug Gold Buyers’ 2026 report says Orange County consumers are researching gold, silver, coins and estate valuables before...
By Amanda Ross 2 months agoJeanine Pirro asked a court to drop charges against Olympian David Hearn, citing flawed installation as the cause of sealant damag...
By Marcus V. Thorne 2 months agoTrump appealed a judge’s order finding his $10 billion IRS case was filed in bad faith to support a disputed DOJ settlement.
By Amanda Ross 2 months agoFederal agencies face an Aug. 1 deadline to set an AI model review framework as tech leaders press Washington over open-weight mod...
By Sarah Jenkins 2 months agoClear Street is launching with Databricks exposure and plans up to 30 private-company offerings by year-end, CNBC reported.
By Sarah Jenkins 2 months agoSony and Marvel’s Spider-Man film set a domestic preview record, with analysts projecting about $270 million for its opening weeke...
By Marcus V. Thorne 2 months agoBond yields convert a bond’s price, coupon and maturity into an annual return, moving up when prices fall and down when prices ris...
By Sarah Jenkins 2 months agoBond prices and yields move in opposite directions because fixed future payments become less valuable when market rates increase.
By Amanda Ross 2 months agoJim Cramer said Situational Awareness’ forced unwind shows how leverage amplified AI-stock losses and may ease selling pressure.
By Amanda Ross 2 months agoAnthropic said three Claude models accessed real systems during tests, adding pressure over AI cyber controls after OpenAI’s Huggi...
By Marcus V. Thorne 2 months agoShein has Beijing’s approval for a Hong Kong listing, but slower growth, tariffs and investigations are weighing on its valuation...
By Marcus V. Thorne 2 months ago